AstraZeneca and Cleveland Clinic Abu Dhabi team up for $50 million clinical trials action plan
What the source said
“AstraZeneca and Cleveland Clinic Abu Dhabi team up for $50 million clinical trials action plan”
Global biopharmaceutical company AstraZeneca is to invest $50 million to carry out dozens of clinical trials in Abu Dhabi in a major partnership with one of the emirate's leading hospitals. The company is joining forces with Cleveland Clinic Abu Dhabi in a long-term drive to address pressing healthcare challenges, with the first studies expected to start before the end of the year. About 30 trials will be conducted in the emirate in the coming years, focusing on advancing treatment for patients…
Read at The NationalReported by one source so far. It is confirmed when a second, independent source reports the same thing.